Does use of alternative medicine delay treatment of head and neck cancer? A surveillance, epidemiology, and end results (SEER) cancer registry study

Head and Neck

Volumn 30, Issue 4, 2008, Pages 446-454

  Kato, Ikuko ^a   Neale, Anne Victoria ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alternative medicine; Complementary medicine; Head and neck cancer; SEER; Treatment delay

Indexed keywords

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CHI GONG; CHIROPRACTIC; DIET THERAPY; ENERGY HEALING; FEEDBACK SYSTEM; FEMALE; HEAD AND NECK CANCER; HEALTH SURVEY; HUMAN; HYPNOSIS; IMAGERY; KAPLAN MEIER METHOD; LARYNX CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MASSAGE; MEDITATION; MOUTH CANCER; MOVEMENT THERAPY; MUSIC THERAPY; PHYSIOTHERAPY; PRIORITY JOURNAL; PSYCHOTHERAPY; QUESTIONNAIRE; RELIGION; SPIRITUAL HEALING; SQUAMOUS CELL CARCINOMA; TAI CHI; TONGUE CANCER; UNITED STATES; URBAN POPULATION; YOGA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMPLEMENTARY THERAPIES; EDUCATIONAL STATUS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCOME; INSURANCE, HEALTH; LYMPHOMA; MALE; MARITAL STATUS; MIDDLE AGED; POPULATION SURVEILLANCE; QUESTIONNAIRES; SEER PROGRAM; TIME FACTORS; UNITED STATES;

EID: 42549115140     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20721     Document Type: Article

References (42)

1. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States 1990-1997: results of a follow-up national survey. JAMA 1998:280: 1569-1575.
2. Vickers AJ, Cassileth BR. Unconventional therapies for cancer and cancer-related symptoms. Lancet Oncol 2001;226-232.
3. White JD. Complementary and alternative medicine research: a National Cancer Institute perspective. Semin Oncol 2002;29:546-551.
4. Weiger WA, Smith M, Boon H, Richardson MA, Kaptchuk TJ, Eisenberg DM. Advising patients who seek complementary and alterative medical therapies for cancer. Ann Intern Med 2002;137:889-903.
5. Bier ID, Wilson J, Studt P, Shakleton M. Auricular acupuncture, education, and smoking cessation: a randomized, sham-controlled trial. Am J Public Health 2002;92: 1642-1647.
6. Risberg T, Vickers A, Bremnes RM, Wist EA, Kaasa S, Caasileth BR. Does use of alternative medicine predict survival from cancer? Eur J Cancer 2003;39:372-377.
7. Davis GE, Bryson CL, Yueh B, McDonell MB, Micek MA, Fihn SD. Treatment delay associated with alternative medicine use among veterans with head and neck cancer. Head Neck 2006;28:926-931.
8. Molassiotis A, Ozden G, Platin N, et al. Complementary and alternative medicine use in patients with head and neck cancers in Europe. Eur J Cancer Care 2006;15:19-24.
9. Warrick PD, Irish JC, Morningstar M, Gilbert R, Brown D, Gullane P. Use of alternative medicine among patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 1999;125:573-579.
10. Ries LAG, Harkins D, Krapcho M, et al, editors. SEER Cancer Statistics Review, 1975-2003. Bethesda, MD: National Cancer Institute. Available at http://seer.cancer.gov/csr/1975_2003/, based on November 2005 SEER data submission, posted to the SEER web site, 2006.
11. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and implications for oncology. J Clin Oncol 2000;18:2505-2514.
12. Schootman M, Jeffe DB, West MM, Aft R. Self-report by elderly breast cancer patients was an acceptable alternative to surveillance, epidemiology, and end results (SEER) abstract data. J Clin Epidemiol 2005;58:1316-1319.
13. Allison PD. Survival analysis using the SAS system. A practical guide. Cary, NC: SAS Institute; 1995.
14. Breslow NE, Day NE. Statistical methods in cancer research, Vol I: the analysis of case-control studies. IARC Scientific Publications No. 32. Lyon, France: IARC; 1980.
15. VandeCreek L, Rogers E, Lester J. Use of alternative therapies among breast cancer outpatients compared with the general population. Altern Ther Health Med 1999;5:71-76.
16. Shen J, Andersen R, Albert PS, et al. Use of complementary/alternative therapies by women with advanced-stage breast cancer. BMC Complement Altern Med 2002; 2:8.
17. Patterson RE, Neuhouser ML, Hedderson MM, et al. Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med 2002;8:477-485.
18. Hedderson MM, Patterson RE, Neuhouser ML, et al. Sex differences in motives for use of complementary and alternative medicine among cancer patients. Altern Ther Health Med 2004;10:58-64.
19. Yates JS, Mustian KM, Morrow GR, et al. Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer 2005; 13:806-811.
20. Astin JA. Why patients use alternative medicine: results of a national study. JAMA 1998;279:1548-1553.
21. Ni H, Simile C, Hardy AM. Utilization of complementary and alternative medicine by United States: results from the 1999 National Health Interview Survey. Med Care 2002;40:353-358.
22. Wolsko PM, Eisenberg DM, Davis RB, Ettner SL, Phillips RS. Insurance coverage, medical conditions, and visits to alternative medicine providers. Arch Intern Med 2002;162:281-287.
23. Lerner IJ, Kennedy BJ. The prevalence of questionable methods of cancer treatment in the United States. CA Cancer J Clin 1992;42:181-191.
24. Lee M, Lin S, Wrensch M, Adler S, Eisenberg D. Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst 2000,92:42-47.
25. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by women with early-stage breast cancer. N Engl J Med 1999;340:1733-1739.
26. Wyatt GK, Friedman LL, Given CW, Given BA, Beckrow KC. Complementary therapy use among older cancer patients. Cancer Pract 1999;7:136-144.
27. Tough SC, Johnston DW, Verhoef MJ, Arthur K, Bryant H. Complementary and alternative medicine use among colorectal cancer patients in Alberta, Canada. Altern Ther Health Med 2002;8:54-64.
28. Dejardin O, Herbert C, Velten M, et al. Social and geographical factors influencing the delay in treatment for colorectal cancer. Br J Cancer 2004;91:1751-1752.
29. Langenbach MR, Schmidt J, Neumann J, Zirngibl H. Delay in treatment of colorectal cancer: multifactorial problem. World J Surg 2003;27:304-308.
30. Brouha X, Tromp D, Hordijk GJ, Winnubst J, De Leeuw R. Role of alcohol and smoking in diagnostic delay of head and neck cancer patients. Acta Otolaryngol 2005; 125:552-556.
31. Pitiphat W, Diehl SR, Laskaris G, Cartsos V, Douglass CW, Zavras AI. Factors associated with delay in the diagnosis of oral cancer. J Dent Res 2002;81:192-197.
32. Druss BG, Rosenheck RA. Association between use of unconventional therapies and conventional medical services. JAMA 1999;282:651-656.
33. Sollner W, Maislinger S, DeVries A, Steixner E, Rumpold G, Lukas P. Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey. Cancer 2000;89: 873-880.
34. Paoloni M, Abdel-Rahman SZ, Sapone A, et al. β-carotene: a cancer chemopreventive agent or a co-carcinogen? Mutat Res 2003;543:195-200.
35. Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and β-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-1035.
36. Bairati I, Meyer F, Jobin E, et al. Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients. Int J Cancer 2006;119: 2221-2224.
37. Burg JA, Allred SL, Sapp JH II. The potential for bias due to attrition in the National Exposure Registry: an examination of reasons for nonresponse, nonrespondent characteristics, and the response rate. Toxicol Ind Health 1997;13:1-13.
38. Heath AC, Howells W, Kirk KM, et al. Predictors of non-response to a questionnaire survey of a volunteer twin panel: findings from the Australian 1989 twin cohort. Twin Res 2001;4:73-80.
39. Korkeila K, Suominen S, Ahvenainen J, et al. Non-response and related factors in a nation-wide health survey. Eur J Epidemiol 2001;17:991-999.
40. Schnoll RA, Rothman RL, Newman H, et al. Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: implications for the development of tobacco control programs for cancer patients. Psychooncology 2004;13:346-358.
41. Picavet HS. National health surveys by mail or home interview: effect on response. J Epidemiol Community Health 2001;55:408-413.
42. US Census Bureau. American Fact Finder. Available at http://factfinder. census.gov/servlet/ [Accessed Nov. 10, 2006].